Theralase Technologies Inc. (TSXV:TLT)
0.2350
0.00 (0.00%)
Jun 12, 2026, 3:58 PM EST
Theralase Technologies Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1 | 0.18 | 0.27 | 0.04 | 1.51 | 3.69 |
Cash & Short-Term Investments | 1 | 0.18 | 0.27 | 0.04 | 1.51 | 3.69 |
Cash Growth | 661.92% | -31.94% | 512.05% | -97.09% | -59.13% | -53.15% |
Accounts Receivable | 0.67 | 0.38 | 0.17 | 0.39 | 0.2 | 0.09 |
Other Receivables | 0.19 | 0.82 | 0.54 | 0.21 | 0.24 | 0.21 |
Receivables | 0.85 | 1.2 | 0.71 | 0.6 | 0.44 | 0.3 |
Inventory | 0.49 | 0.51 | 0.55 | 0.66 | 0.49 | 0.57 |
Prepaid Expenses | 0.19 | 0.14 | 0.06 | 0.2 | 0.07 | 0.44 |
Total Current Assets | 2.53 | 2.03 | 1.58 | 1.5 | 2.5 | 5 |
Property, Plant & Equipment | 0.39 | 0.45 | 0.61 | 0.86 | 1.11 | 0.87 |
Long-Term Accounts Receivable | 0.97 | 1.02 | 1.06 | 0.92 | 0.55 | 0.08 |
Total Assets | 3.89 | 3.49 | 3.25 | 3.28 | 4.16 | 5.94 |
Accounts Payable | 1.03 | 0.79 | 0.36 | 0.68 | 0.33 | 0.5 |
Accrued Expenses | 0.48 | 0.47 | 0.52 | 0.3 | 0.27 | 0.34 |
Short-Term Debt | 0.26 | 0.26 | - | - | - | - |
Current Portion of Leases | 0.08 | 0.11 | 0.1 | 0.09 | 0.09 | 0.04 |
Other Current Liabilities | 0 | - | - | - | - | - |
Total Current Liabilities | 1.85 | 1.62 | 0.99 | 1.08 | 0.68 | 0.87 |
Long-Term Leases | 0.09 | 0.09 | 0.19 | 0.29 | 0.39 | - |
Total Liabilities | 1.94 | 1.72 | 1.18 | 1.37 | 1.07 | 0.87 |
Common Stock | 51.55 | 50.89 | 48.92 | 46.44 | 44.53 | 42.12 |
Additional Paid-In Capital | 18.27 | 18.16 | 17.58 | 12.49 | 11.37 | 10.94 |
Retained Earnings | -72.65 | -71.62 | -67.5 | -63.24 | -58.45 | -53.09 |
Comprehensive Income & Other | 4.78 | 4.35 | 3.06 | 6.22 | 5.64 | 5.1 |
Shareholders' Equity | 1.95 | 1.78 | 2.07 | 1.91 | 3.09 | 5.07 |
Total Liabilities & Equity | 3.89 | 3.49 | 3.25 | 3.28 | 4.16 | 5.94 |
Total Debt | 0.43 | 0.46 | 0.29 | 0.39 | 0.47 | 0.04 |
Net Cash (Debt) | 0.57 | -0.28 | -0.03 | -0.34 | 1.03 | 3.66 |
Net Cash Growth | - | - | - | - | -71.69% | -53.06% |
Net Cash Per Share | 0.00 | -0.00 | -0.00 | -0.00 | 0.00 | 0.02 |
Filing Date Shares Outstanding | 295.67 | 275.82 | 248.81 | 235.13 | 216.5 | 204.43 |
Total Common Shares Outstanding | 269.24 | 265 | 247.78 | 228.46 | 216.5 | 204.28 |
Working Capital | 0.69 | 0.4 | 0.6 | 0.42 | 1.82 | 4.12 |
Book Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
Tangible Book Value | 1.95 | 1.78 | 2.07 | 1.91 | 3.09 | 5.07 |
Tangible Book Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
Machinery | 1.51 | 1.65 | 1.68 | 1.66 | 1.76 | 1.69 |
Leasehold Improvements | 0.01 | 0.01 | 0.03 | 0.03 | 0.26 | 0.26 |